MediRita
Startup Company for Artificial Intelligence in the area of Drug Discovery
Who are we?
We aim at the healthy life of human being.
We pursue for people to benefit from the new drugs.
We focus on artificial intelligence that accelerates the development of new drugs
that treat various diseases especially including rare diseases.
Multi-omics based whole-body simulation
New Drug development costs
Economy of a new drug
New Drug development period
New drug benefits
Article
제목
매체
날짜
Photo
Our vigorous external activities.
Team
YoungWoo Pae, Ph.D.
Co-Founder, Chief Executive Officer
Former IBM Executive for Watson
Expert Council, KPBMA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association)
JungWoo Woo
Software Engineer
Seung-Hyun Jin, Ph.D.
Co-Founder, Chief Science Officer
Ph.D. in Physics, KAIST
Former Assistant Professor, Seoul National University Hospital
HyeongHwan Kim
Software Engineer
HeungSoo Kim, Ph.D.
Director of Business Leader
Former industry-academy cooperation professor, Chungnam National Uni.
SeungHyeon Choi
Data Scientist
Biotechnology
SeongGyu Kim
Data Scientist
Chemical&Biological Engineering
Advisor
Young Gyu Cho, Ph.D.
Executive Vice President / CTO
GI Innovation
Ph.D. in Life Science, POSTECH
Former Director of Research, HANDOK
Partners
Contact us
Tel: 02-890-0779
Fax: 02-890-0780
#803, 8F, Mario Tower, 28, Digital-ro 30-gil, Guro-gu, Seoul, Republic of Korea
Directions
Guro Digital Complex Station EXIT 3, Walk for 8 minutes